In PD, for example, levodopa-induced dyskinesia is thought to be induced by D1-receptor-mediated phosphorylation of mTORC1, a hypothesis supported by the fact that genetic variability in mTOR pathway components is associated with PD dyskinesia (Zhu et al., 2019). This evidence concerns the gene MTOR and drug-induced dyskinesia.